Atlas Trials

Erasca, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Erasca, Inc.

RecordFirmDate
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. (NCT07021898)Erasca, Inc.2025-08-06
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors (NCT06983743)Erasca, Inc.2025-06-05
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations (NCT05907304)Erasca, Inc.2023-08-17
A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies (NCT05279859)Erasca, Inc.2022-03-15
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies (NCT05039177)Erasca, Inc.2021-09-20
A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors (NCT04866134)Erasca, Inc.2021-05-07
A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors (NCT04670679)Erasca, Inc.2020-12-15

Track Erasca, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.